Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Phathom Pharmaceuticals, Inc. (PHAT) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2023 SC 13D/A Frazier Life Sciences Public Fund, L.P. reports a 18.5% stake in Phathom Pharmaceuticals, Inc.
05/05/2023 SC 13D/A Frazier Life Sciences Public Fund, L.P. reports a 19.3% stake in Phathom Pharmaceuticals, Inc.
09/26/2022 SC 13D/A Frazier Life Sciences IX, L.P. reports a 21.5% stake in Phathom Pharmaceuticals, Inc.
08/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/06/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/01/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/23/2020 SC 13D/A Frazier Life Sciences IX, L.P. reports a 18.7% stake in Phathom Pharmaceuticals, Inc.
01/27/2020 SC 13D/A TAKEDA PHARMACEUTICAL CO LTD reports a 27% stake in Phathom Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy